Revvity | 股本和储备



金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 12.05B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
USD 49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


股本和储备 更改 日
Agilent USD 6.91B 167M 2025-12
Align Technology USD 3.96B 44.68M 2025-09
Bio Techne USD 2.01B 45.18M 2025-12
Bio-Rad Laboratories USD 7.45B 716.8M 2025-12
Bruker USD 2.49B 625.6M 2025-09
Celltrion KRW 16.7T 182.36B 2025-09
Charles River Laboratories USD 3.16B 240.82M 2025-12
Cspc Pharmaceutical CNY 33.25B 984.93M 2025-06
Danaher USD 52.53B 1.46B 2025-12
Dentsply International USD 1.48B 482M 2025-09
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 546.45M 243.38M 2025-09
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Exact Sciences USD 2.4B 100.37M 2025-12
Hologic USD 5.25B 197.2M 2025-12
Illumina USD 2.72B 342M 2025-12
Intuitive Surgical USD 17.82B 894.3M 2025-12
IQVIA Holdings USD 6.5B 343M 2025-12
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Laboratory Of America USD 8.62B 93.2M 2025-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 55.1M 229K 2025-06
Mesa Laboratories USD 186.69M 8.22M 2025-12
Mettler Toledo International USD -23.64M 225.56M 2025-12
Myriad Genetics USD 372.8M 15.3M 2025-09
Neuren Pharmaceuticals AUD 323.27M 40.63M 2025-06
OraSure Technologies USD 361.98M 18.74M 2025-09
Organigram Holdings CAD 349.13M 36.37M 2025-09
Ovoca Bio EUR 8.67M 4.76M 2022-06
Pacific Biosciences Of California USD 36.09M 25.4M 2025-09
Pharma Mar EUR 197.51M 4.02M 2025-09
Qiagen NV USD 3.78B 128.73M 2025-12
Quest Diagnostics USD 7.17B 88M 2025-12
Quidel USD 1.92B 115.9M 2025-12
Repligen USD 2.11B 1.66B 2025-12
Revvity USD 7.38B 180.27M 2025-09
Sartorius EUR 2.67B 9.9M 2025-09
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Tilray USD 1.51B 1.22B 2025-03
Waters USD 2.56B 230.55M 2025-12
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09


Revvity 股本和储备 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.